Archives of Gerontology and Geriatrics
Fecha de publicación: 22 september 2018
DOI: https://doi.org/10.1016/j.archger.2018.09.005
Autores: Scott Martin Vouri, Mario Schootman, Seth A.Strope, Hong Xian, Margaret A.Olsen
Background: Although antimuscarinics are typically the first-line pharmacological treatment option for overactive bladder, patients often discontinue therapy. The aim of this research project is to identify the rate of antimuscarinic discontinuation, switching, and continuation and differences in discontinuation among different antimuscarinics.
